GRCh38/hg38 10q23.33-25.3(chr10:95112607-116776637)x3 |
copy number gain |
See cases [RCV000050747] |
Chr10:95112607..116776637 [GRCh38] Chr10:96872364..118383651 [GRCh37] Chr10:96862354..118526138 [NCBI36] Chr10:10q23.33-25.3 |
pathogenic |
GRCh38/hg38 10q24.32-24.33(chr10:102243341-103929730)x1 |
copy number loss |
See cases [RCV000052568] |
Chr10:102243341..103929730 [GRCh38] Chr10:104003098..105689488 [GRCh37] Chr10:103993088..105679478 [NCBI36] Chr10:10q24.32-24.33 |
pathogenic |
GRCh38/hg38 10q23.31-26.3(chr10:91048545-133620674)x3 |
copy number gain |
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053560]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053560]|See cases [RCV000053560] |
Chr10:91048545..133620674 [GRCh38] Chr10:92808302..135434178 [GRCh37] Chr10:92798282..135284168 [NCBI36] Chr10:10q23.31-26.3 |
pathogenic |
GRCh38/hg38 10q24.31-26.3(chr10:100194215-132432797)x3 |
copy number gain |
See cases [RCV000053564] |
Chr10:100194215..132432797 [GRCh38] Chr10:101953972..134246301 [GRCh37] Chr10:101943962..134096291 [NCBI36] Chr10:10q24.31-26.3 |
pathogenic |
NM_005736.3(ACTR1A):c.1017C>T (p.Ser339=) |
single nucleotide variant |
Malignant melanoma [RCV000068777] |
Chr10:102481143 [GRCh38] Chr10:104240900 [GRCh37] Chr10:104230890 [NCBI36] Chr10:10q24.32 |
not provided |
GRCh38/hg38 10q24.31-26.3(chr10:100600492-133622588)x3 |
copy number gain |
See cases [RCV000137747] |
Chr10:100600492..133622588 [GRCh38] Chr10:102360249..135436092 [GRCh37] Chr10:102350239..135286082 [NCBI36] Chr10:10q24.31-26.3 |
pathogenic |
GRCh37/hg19 10q24.32-26.3(chr10:103288313-135512075)x3 |
copy number gain |
See cases [RCV000240457] |
Chr10:103288313..135512075 [GRCh37] Chr10:10q24.32-26.3 |
pathogenic |
GRCh37/hg19 10q23.1-25.1(chr10:85557432-105804295)x1 |
copy number loss |
Poly (ADP-Ribose) polymerase inhibitor response [RCV000431909] |
Chr10:85557432..105804295 [GRCh37] Chr10:10q23.1-25.1 |
pathogenic|drug response |
GRCh37/hg19 10p15.3-q26.3(chr10:93297-135378918)x3 |
copy number gain |
See cases [RCV000448750] |
Chr10:93297..135378918 [GRCh37] Chr10:10p15.3-q26.3 |
pathogenic |
GRCh37/hg19 10q24.2-26.3(chr10:100780957-135427143)x3 |
copy number gain |
See cases [RCV000446733] |
Chr10:100780957..135427143 [GRCh37] Chr10:10q24.2-26.3 |
pathogenic |
GRCh37/hg19 10q24.32-25.3(chr10:104030479-115410590)x1 |
copy number loss |
See cases [RCV000448581] |
Chr10:104030479..115410590 [GRCh37] Chr10:10q24.32-25.3 |
pathogenic |
GRCh37/hg19 10p15.3-q26.3(chr10:100027-135427143) |
copy number gain |
See cases [RCV000511389] |
Chr10:100027..135427143 [GRCh37] Chr10:10p15.3-q26.3 |
pathogenic|uncertain significance |
GRCh37/hg19 10q23.32-26.3(chr10:93283493-135427143)x3 |
copy number gain |
See cases [RCV000510972] |
Chr10:93283493..135427143 [GRCh37] Chr10:10q23.32-26.3 |
pathogenic |
GRCh37/hg19 10q11.21-26.3(chr10:42347406-135534747)x1 |
copy number loss |
Poly (ADP-Ribose) polymerase inhibitor response [RCV000626438] |
Chr10:42347406..135534747 [GRCh37] Chr10:10q11.21-26.3 |
drug response |
GRCh37/hg19 10q23.33-26.3(chr10:94346520-135427143)x3 |
copy number gain |
not provided [RCV000683291] |
Chr10:94346520..135427143 [GRCh37] Chr10:10q23.33-26.3 |
pathogenic |
GRCh37/hg19 10q24.32-24.33(chr10:103891057-105339973)x1 |
copy number loss |
not provided [RCV000683260] |
Chr10:103891057..105339973 [GRCh37] Chr10:10q24.32-24.33 |
likely pathogenic |
GRCh37/hg19 10p15.3-q26.3(chr10:98087-135477883)x3 |
copy number gain |
not provided [RCV000749465] |
Chr10:98087..135477883 [GRCh37] Chr10:10p15.3-q26.3 |
pathogenic |
GRCh37/hg19 10q24.32(chr10:104031306-104366150)x3 |
copy number gain |
not provided [RCV002473842] |
Chr10:104031306..104366150 [GRCh37] Chr10:10q24.32 |
uncertain significance |
NC_000010.10:g.(?_99344461)_(105992004_?)dup |
duplication |
not provided [RCV003107322] |
Chr10:99344461..105992004 [GRCh37] Chr10:10q24.2-25.1 |
uncertain significance |
GRCh37/hg19 10q24.32-25.3(chr10:104030479-115410590) |
copy number loss |
not specified [RCV002052885] |
Chr10:104030479..115410590 [GRCh37] Chr10:10q24.32-25.3 |
pathogenic |
NM_005736.4(ACTR1A):c.924A>T (p.Lys308Asn) |
single nucleotide variant |
not specified [RCV004168059] |
Chr10:102482002 [GRCh38] Chr10:104241759 [GRCh37] Chr10:10q24.32 |
uncertain significance |
NM_005736.4(ACTR1A):c.281A>G (p.Tyr94Cys) |
single nucleotide variant |
not specified [RCV004163990] |
Chr10:102488184 [GRCh38] Chr10:104247941 [GRCh37] Chr10:10q24.32 |
uncertain significance |
NM_005736.4(ACTR1A):c.587T>A (p.Leu196His) |
single nucleotide variant |
not specified [RCV004157925] |
Chr10:102484230 [GRCh38] Chr10:104243987 [GRCh37] Chr10:10q24.32 |
uncertain significance |
GRCh37/hg19 10p14-q26.3(chr10:11138692-135427143) |
copy number gain |
Distal trisomy 10q [RCV003319593] |
Chr10:11138692..135427143 [GRCh37] Chr10:10p14-q26.3 |
pathogenic |
GRCh37/hg19 10q23.33-26.3(chr10:95078198-135427143)x3 |
copy number gain |
not specified [RCV003986893] |
Chr10:95078198..135427143 [GRCh37] Chr10:10q23.33-26.3 |
pathogenic |
NC_000010.11:g.(102444036_?)_(?_104726221)del |
deletion |
Desmoplastic/nodular medulloblastoma [RCV000003754] |
Chr10:102444036..104726221 [GRCh38] Chr10:10q24.32-25.1 |
pathogenic |
NM_005736.4(ACTR1A):c.803T>C (p.Ile268Thr) |
single nucleotide variant |
not specified [RCV004433732] |
Chr10:102482123 [GRCh38] Chr10:104241880 [GRCh37] Chr10:10q24.32 |
uncertain significance |
NM_005736.4(ACTR1A):c.574C>T (p.Arg192Cys) |
single nucleotide variant |
not specified [RCV004604891] |
Chr10:102484243 [GRCh38] Chr10:104244000 [GRCh37] Chr10:10q24.32 |
uncertain significance |
NM_005736.4(ACTR1A):c.114T>C (p.Tyr38=) |
single nucleotide variant |
not specified [RCV004604901] |
Chr10:102489138 [GRCh38] Chr10:104248895 [GRCh37] Chr10:10q24.32 |
likely benign |
Single allele |
deletion |
See cases [RCV004727573] |
Chr10:102837530..105033440 [GRCh37] Chr10:10q24.31-24.33 |
pathogenic |
NM_005736.4(ACTR1A):c.800T>C (p.Leu267Ser) |
single nucleotide variant |
not specified [RCV004898214] |
Chr10:102482126 [GRCh38] Chr10:104241883 [GRCh37] Chr10:10q24.32 |
uncertain significance |
NM_005736.4(ACTR1A):c.238G>A (p.Val80Ile) |
single nucleotide variant |
not specified [RCV004898207] |
Chr10:102488227 [GRCh38] Chr10:104247984 [GRCh37] Chr10:10q24.32 |
uncertain significance |
GRCh37/hg19 10p15.3-q26.3(chr10:100027-135427143)x3 |
copy number gain |
See cases [RCV000510861] |
Chr10:100027..135427143 [GRCh37] Chr10:10p15.3-q26.3 |
pathogenic |
GRCh37/hg19 10p15.3-q26.3(chr10:73232-135524321)x3 |
copy number gain |
not provided [RCV000749464] |
Chr10:73232..135524321 [GRCh37] Chr10:10p15.3-q26.3 |
pathogenic |
NM_005736.4(ACTR1A):c.590A>G (p.Tyr197Cys) |
single nucleotide variant |
not specified [RCV004133694] |
Chr10:102484227 [GRCh38] Chr10:104243984 [GRCh37] Chr10:10q24.32 |
uncertain significance |
GRCh37/hg19 10p13-q26.3(chr10:12829206-135427143) |
copy number loss |
Distal 10q deletion syndrome [RCV003319583] |
Chr10:12829206..135427143 [GRCh37] Chr10:10p13-q26.3 |
pathogenic |
NM_005736.4(ACTR1A):c.380T>G (p.Val127Gly) |
single nucleotide variant |
not specified [RCV004898222] |
Chr10:102485669 [GRCh38] Chr10:104245426 [GRCh37] Chr10:10q24.32 |
uncertain significance |
NM_005736.4(ACTR1A):c.209C>T (p.Ser70Leu) |
single nucleotide variant |
not specified [RCV004898227] |
Chr10:102488256 [GRCh38] Chr10:104248013 [GRCh37] Chr10:10q24.32 |
uncertain significance |
NM_005736.4(ACTR1A):c.133G>A (p.Val45Ile) |
single nucleotide variant |
not specified [RCV004898206] |
Chr10:102489119 [GRCh38] Chr10:104248876 [GRCh37] Chr10:10q24.32 |
uncertain significance |